Roles of epidermal growth factor family in the regulation of postnatal somatic growth

Endocrine Reviews

Volumn 28, Issue 3, 2007, Pages 284-296

  Xian, Cory J ^a,b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; BETACELLULIN; CYTOKINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; EPIREGULIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA;

BODY COMPOSITION; BODY GROWTH; BONE DEVELOPMENT; BONE GROWTH; BONE MATRIX; BONE MINERALIZATION; BONE PLATE; BONE REMODELING; CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; DIMERIZATION; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; INTESTINE; LIGAND BINDING; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PERINATAL DEVELOPMENT; PLURIPOTENT STEM CELL; POSTNATAL GROWTH; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW;

ANIMALS; BODY COMPOSITION; BONE DEVELOPMENT; BONE REMODELING; EPIDERMAL GROWTH FACTOR; GROWTH; HUMANS; MULTIGENE FAMILY; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 34347222589     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2006-0049     Document Type: Review

References (152)

1. Lee DC, Fenton SE, Berkowitz EA, Hissong MA 1995 Transforming growth factor α: expression, regulation, and biological activities. Pharmacol Rev 47:51-85
2. Pinkas-Kramarski R, Alroy I, Yarden Y 1997 ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling. J Mamm Gland Biol Neoplasia 2:97-107
3. Gassmann M, Lemke G 1997 Neuregulins and neuregulin receptors in neural development. Curr Opin Neurobiol 7:87-92
4. Mirsky R, Jessen KR 1999 The neurobiology of Schwann cells. Brain Pathol 9:293-311
5. Vartanian T, Fischbach G, Miller R 1999 Failure of spinal cord oligodendrocyte development in mice lacking neuregulin. Proc Natl Acad Sci USA 96:731-735
6. Esper RM, Pankonin MS, Loeb JA 2006 Neuregulins: versatile growth and differentiation factors in nervous system development and human disease. Brain Res Rev 51:161-175
7. Prigent SA, Lemoine NR 1992 The type 1 (EGFR-related) family of growth factor receptors and their ligands. Prog Growth Factor Res 4:1-24
8. Carpenter CD, Ingraham HA, Cochet C, Walton GM, Lazar CS, Sowadski JM, Rosenfeld MG, Gill GN 1991 Structural analysis of the transmembrane domain of the epidermal growth factor receptor. J Biol Chem 266:5750-5755
9. Tzahar E, Pinkas-Kramarski R, Moyer JD, Klapper LN, Alroy I, Levkowitz G, Shelly M, Henis S, Eisenstein M, Ratzkin BJ, Sela M, Andrews GC, Yarden Y 1997 Bivalence of EGF-like ligands drives the ErbB signaling network. EMBO J 16:4938-4950
10. Carpenter G 2000 The EGF receptor: a nexus for trafficking and signaling. Bioessays 22:697-707
11. Sweeney C, Carraway 3rd KL 2000 Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage. Oncogene 19:5568-5573
12. Burgering BM, Coffer PJ 1995 Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599-602
13. Alroy I, Yarden Y 1997 The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 410:83-86
14. Silberstein GB 2001 Postnatal mammary gland morphogenesis. Microsc Res Tech 52:155-162
15. Xian CJ, Zhou X-F 2000 Roles of transforming growth factor-α and related molecules in the nervous system. Mol Neurobiol 20:157-183
16. Xian CJ, Zhou XF 2004 EGF family of growth factors: essential roles and functional redundancy in the nerve system. Front Biosci 9:85-92
17. Barnard JA, Beauchamp RD, Russell WE, Dubois RN, Coffey RJ 1995 Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 108:564-580
18. Dignass AU, Sturm A 2001 Peptide growth factors in the intestine. Eur J Gastroenterol Hepatol 13:763-770
19. Xian CJ, Cool JC, Howarth GS, Read LC 2002 Effects of TGF-α gene knockout on epithelial cell kinetics and repair of methotrexateinduced damage in mouse small intestine. J Cell Physiol 191:105-115
20. Xian CJ 2003 Roles of growth factors in chemotherapy-induced intestinal mucosal damage repair. Curr Pharm Biotechnol 4:260-269
21. Lonnerdal B 2003 Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr 77:1537S-1543S
22. Schroeder JA, Lee DC 1998 Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ 9:451-464
23. Luetteke NC, Qiu TH, Fenton SE, Troyer KL, Riedel RF, Chang A, Lee DC 1999 Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126:2739-2750
24. Schroeder JA, Troyer KL, Lee DC 2000 Cooperative induction of mammary tumorigenesis by TGF-α and Wnts. Oncogene 19:3193-3199
25. Troyer KL, Lee DC 2001 Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network. J Mamm Gland Biol Neoplasia 6:7-21
26. Kenney NJ, Bowman A, Korach KS, Barrett JC, Salomon DS 2003 Effect of exogenous epidermal-like growth factors on mammary gland development and differentiation in the estrogen receptor-α knockout (ERKO) mouse. Breast Cancer Res Treat 79:161-173
27. Carraway KL, Price-Schiavi SA, Komatsu M, Idris N, Perez A, Li P, Jepson S, Zhu X, Carvajal ME, Carraway CA 2000 Multiple facets of sialomucin complex/MUC4, a membrane mucin and erbb2 ligand, in tumors and tissues (Y2K update). Front Biosci 5:D95-D107
28. Price-Schiavi SA, Andrechek E, Idris N, Li P, Rong M, Zhang J, Carothers Carraway CA, Muller WJ, Carraway KL 2005 Expression, location, and interactions of ErbB2 and its intramembrane ligand Muc4 (sialomucin complex) in rat mammary gland during pregnancy. J Cell Physiol 203:44-53
29. Kajikawa K, Yasui W, Sumiyoshi H, Yoshida K, Nakayama H, Ayhan A, Yokozaki H, Ito H, Tahara E 1991 Expression of epidermal growth factor in human tissues. Immunohistochemical and biochemical analysis. Virchows Arch A Pathol Anat Histopathol 418:27-32
30. Sheffield LG 1990 Effect of sialoadenectomy on the ability of mouse serum to induce deoxyribonucleic acid synthesis in mammary epithelial cells: possible role of epidermal growth factor. J Dairy Sci 73:2087-2092
31. Okamoto S, Oka T 1984 Evidence for physiological function of epidermal growth factor: pregestational sialoadenectomy of mice decreases milk production and increases offspring mortality during lactation period. Proc Natl Acad Sci USA 81:6059-6063
32. Sheffield LG, Welsch CW 1987 Influence of submandibular salivary glands on hormone responsiveness of mouse mammary glands. Proc Soc Exp Biol Med 186:368-377
33. Miettinen PJ, Berger JE, Meneses J, Phung Y, Pedersen RA, Werb Z, Derynck R 1995 Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376:337-341
34. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, Barnard JA, Yuspa SH, Coffey RJ, Magnuson T 1995 Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269:230-234
35. Sibilia M, Steinbach JP, Stingl L, Aguzzi A, Wagner EF 1998 A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor. EMBO J 17:719-731
36. Luetteke NC, Qiu TH, Peiffer RL, Oliver P, Smithies O, Lee DC 1993 TGF-α deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73:263-278
37. Schneider MR, Dahlhoff M, Herbach N, Renner-Mueller I, Dalke C, Puk O, Graw J, Wanke R, Wolf E 2005 Betacellulin overexpression in transgenic mice causes disproportionate growth, pulmonary hemorrhage syndrome, and complex eye pathology. Endocrinology 146:5237-5246
38. Troyer KL, Luetteke NC, Saxon ML, Qiu TH, Xian CJ, Lee DC 2001 Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGF-α. Gastroenterology 121:68-78
39. Hoath SB 1986 Treatment of the neonatal rat with epidermal growth factor: differences in time and organ response. Pediatr Res 20:468-472
40. Hoath SB, Pickens WL, Donnelly MM 1988 Epidermal growth factor-induced growth retardation in the newborn rat: quantitation and relation to changes in skin temperature and viscoelasticity. Growth Dev Aging 52:77-83
41. Webber EM, Wu JC, Wang L, Merlino G, Fausto N 1994 Overexpression of transforming growth factor-α causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol 145:398-408
42. Chan SY, Wong RW 2000 Expression of epidermal growth factor in transgenic mice causes growth retardation. J Biol Chem 275: 38693-38698
43. Provenzano AP, Besner GE, James PF, Harding PA 2005 Heparin-binding EGF-like growth factor (HB-EGF) overexpression in transgenic mice downregulates insulin-like growth factor binding protein (IGFBP)-3 and -4 mRNA. Growth Factors 23:19-31
44. Veldhuis JD, Roemmich JN, Richmond EJ, Rogol AD, Lovejoy JC, Sheffield-Moore M, Mauras N, Bowers CY 2005 Endocrine control of body composition in infancy, childhood, and puberty. Endocr Rev 26:114-146
45. Serrero G, Mills D 1991 Physiological role of epidermal growth factor on adipose tissue development in vivo. Proc Natl Acad Sci USA 88:3912-3916
46. Howarth GS, Bastian SE, Dunbar AJ, Goddard C 2003 Betacellulin promotes growth of the gastrointestinal organs and effects a diuresis in normal rats. Growth Factors 21:79-86
47. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC 1990 Overexpression of TGF-α in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61:1121-1135
48. Pedersen SB, Kristensen K, Bruun JM, Flyvbjerg A, Vinter-Jensen L, Richelsen B 2000 Systemic administration of epidermal growth factor increases UCP3 mRNA levels in skeletal muscle and adipose tissue in rats. Biochem Biophys Res Commun 279:914-919
49. Kristensen K, Pedersen SB, Vinter-Jensen L, Flyvbjerg A, Richelsen B 1998 Systemic administration of epidermal growth factor reduces fat mass in rats: effects on the hormone-sensitive-lipase, lipoprotein lipase and leptin. Horm Res 50:292-296
50. Ianotti JP 1990 Growth plate physiology and pathology. Orthop Clin N Am 21:1-17
51. Karsenty G, Wagner EF 2002 Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2:389-406
52. Xian CJ, Foster BK 2006 The biologic aspects of children's fractures. In: Beaty J, Kasser J, eds. Fractures in children. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 21-50
53. van der Eerden BC, Karperien M, Wit JM 2003 Systemic and local regulation of the growth plate. Endocr Rev 24:782-801
54. Price JS, Oyajobi BO, Russell RG 1994 The cell biology of bone growth. Eur J Clin Nutr 48(Suppl 1):S131-S149
55. Daughaday WH, Hall K, Raben MS, Salmon Jr WD, van den Brande JL, van Wyk JJ 1972 Somatomedin: proposed designation for sulphation factor. Nature 235:107
56. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ 1996 Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273:613-622
57. Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, Le Merrer M, Munnich A 1996 Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia. Horm Res 45:108-110
58. Mancilla EE, De Luca F, Uyeda JA, Czerwiec FS, Baron J 1998 Effects of fibroblast growth factor-2 on longitudinal bone growth. Endocrinology 139:2900-2904
59. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357
60. Gerber H-P, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N 1999 VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623-628
61. Boyle WJ, Simonet WS, Lacey DL 2003 Osteoclast differentiation and activation. Nature 423:337-342
62. Vanderschueren D, Vandenput L, Boonen S 2005 Reversing sex steroid deficiency and optimizing skeletal development in the adolescent with gonadal failure. Endocr Dev 8:150-165
63. DeLise AM, Fischer L, Tuan RS 2000 Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage 8:309-334
64. Manolagas SC 2000 Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115-137
65. Minina E, Kreschel C, Naski MC, Ornitz DM, Vortkamp A 2002 Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev Cell 3:439-449
66. Ornitz DM, Marie PJ 2002 FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16:1446-1465
67. Shum L, Nuckolls G 2002 The life cycle of chondrocytes in the developing skeleton. Arthritis Res 4:94-106
68. Ballock RT, O'Keefe RJ 2003 The biology of the growth plate. J Bone Joint Surg Am 85-A:715-726
69. Harada S, Rodan GA 2003 Control of osteoblast function and regulation of bone mass. Nature 423:349-355
70. Wang J, Zhou J, Cheng CM, Kopchick JJ, Bondy CA 2004 Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth. J Endocrinol 180:247-255
71. Janssens K, ten Dijke P, Janssens S, Van Hul W 2005 Transforming growth factor-β1 to the bone. Endocr Rev 26:743-774
72. Kronenberg HM 2006 PTHrP and skeletal development. Ann NY Acad Sci 1068:1-13
73. Glass 2nd DA, Karsenty G 2006 Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway. Curr Top Dev Biol 73:43-84
74. Huang L, Solursh M, Sandra A 1996 The role of transforming growth factor α in rat craniofacial development and chondrogenesis. J Anat 189:73-86
75. Dealy CN, Scranton V, Cheng HC 1998 Roles of transforming growth factor-α and epidermal growth factor in chick limb development. Dev Biol 202:43-55
76. Sandell LJ, Adler P 1999 Developmental patterns of cartilage. Front Biosci 4:D731-D742
77. Yoon YM, Oh CD, Kim DY, Lee YS, Park JW, Huh TL, Kang SS, Chun JS 2000 Epidermal growth factor negatively regulates chondrogenesis of mesenchymal cells by modulating the protein kinase C-α, Erk-1, and p38 MAPK signaling pathways. J Biol Chem 275: 12353-12359
78. Halevy O, Schindler D, Hurwitz S, Pines M 1991 Epidermal growth factor receptor gene expression in avian epiphyseal growth-plate cartilage cells: effect of serum, parathyroid hormone and atrial natriuretic peptide. Mol Cell Endocrinol 75:229-235
79. Monsonego E, Halevy O, Gertler A, Hurwitz S, Pines M 1995 Growth hormone inhibits differentiation of avian epiphyseal growth-plate chondrocytes. Mol Cell Endocrinol 114:35-42
80. Sibilia M, Wagner B, Hoebertz A, Elliott C, Marino S, Jochum W, Wagner EF 2003 Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart. Development 130:4515-4525
81. Bonassar LJ, Trippel SB 1997 Interaction of epidermal growth factor and insulin-like growth factor-I in the regulation of growth plate chondrocytes. Exp Cell Res 234:1-6
82. Beresford JN 1989 Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop 240:278-280
83. Kember NF 1993 Cell kinetics and the control of bone growth. Acta Paediatr Suppl 82(Suppl 391):61-65
84. Long MW 2001 Osteogenesis and bone-marrow-derived cells. Blood Cells Mol Dis 27:677-690
85. Martineau-Doize B, Lai WH, Warshawsky H, Bergeron JJ 1988 In vivo demonstration of cell types in bone that harbor epidermal growth factor receptors. Endocrinology 123:841-858
86. Davideau JL, Sahlberg C, Thesleff I, Berdal A 1995 EGF receptor expression in mineralized tissues: an in situ hybridization and immunocytochemical investigation in rat and human mandibles. Connect Tissue Res 32:47-53
87. Qin L, Tamasi J, Raggatt L, Li X, Feyen JH, Lee DC, Dicicco-Bloom E, Partridge NC 2005 Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation. J Biol Chem 280:3974-3981
88. Barling PM, Lai AK, Nicholson LF 2005 Distribution of EGF and its receptor in growing red deer antler. Cell Biol Int 29:229-236
89. Chien HH, Lin WL, Cho MI 2000 Down-regulation of osteoblastic cell differentiation by epidermal growth factor receptor. Calcif Tissue Int 67:141-150
90. Ng KW, Partridge NC, Niall M, Martin TJ 1983 Stimulation of DNA synthesis by epidermal growth factor in osteoblast-like cells. Calcif Tissue Int 35:624-628
91. Fang MA, Kujubu DA, Hahn TJ 1992 The effects of prostaglandin E2, parathyroid hormone, and epidermal growth factor on mitogenesis, signaling, and primary response genes in UMR 106-01 osteoblast-like cells. Endocrinology 131:2113-2119
92. Kumegawa M, Hiramatsu M, Hatakeyama K, Yajima T, Kodama H, Osaki T, Kurisu K 1983 Effects of epidermal growth factor on osteoblastic cells in vitro. Calcif Tissue Int 35:542-548
93. Hata R, Hori H, Nagai Y, Tanaka S, Kondo M, Hiramatsu M, Utsumi N, Kumegawa M 1984 Selective inhibition of type I collagen synthesis in osteoblastic cells by epidermal growth factor. Endocrinology 115:867-876
94. Potts JT 2005 Parathyroid hormone: past and present. J Endocrinol 187:311-325
95. Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler DL, McClung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK 2005 Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 26:688-703
96. Partridge NC, Li X, Qin L 2006 Understanding parathyroid hormone action. Ann NY Acad Sci 1068:187-193
97. Thomas T 2006 Intermittent parathyroid hormone therapy to increase bone formation. Joint Bone Spine 73:262-269
98. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC 1999 Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439-446
99. Whitfield JF, Morley P, Willick GE 2002 Parathyroid hormone, its fragments and their analogs for the treatment of osteoporosis. Trent Endocrinol 1:175-190
100. Poole KE, Reeve J 2005 Parathyroid hormone - a bone anabolic and catabolic agent. Curr Opin Pharmacol 5:612-617
101. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A 1997 Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 99:2961-2970
102. Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR, Chandrasekhar S, Martin TJ, Onyia JE 2001 Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142:4047-4054
103. Locklin RM, Khosla S, Turner RT, Riggs BL 2003 Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. J Cell Biochem 89:180-190
104. Drake MT, Baldassare JJ, McConkey CL, Gonzalez EA, Martin KJ 1994 Parathyroid hormone increases the expression of receptors for epidermal growth factor in UMR 106-01 cells. Endocrinology 134: 1733-1737
105. Gonzalez EA, Martin KJ 1996 Retinoids modulate the effect of PTH and calcitriol on EGF receptor expression in UMR 106-01 cells. Calcif Tissue Int 58:429-434
106. Gonzalez EA, Disthabanchong S, Kowalewski R, Martin KJ 2002 Mechanisms of the regulation of EGF receptor gene expression by calcitriol and parathyroid hormone in UMR106-01 cells. Kidney Int 61:1627-1634
107. Ahmed I, Gesty-Palmer D, Drezner MK, Luttrell LM 2003 Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 α-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts. Mol Endocrinol 17:1607-1621
108. Qin L, Qiu P, Wang L, Li X, Swarthout JT, Soteropoulos P, Tolias P, Partridge NC 2003 Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics. J Biol Chem 278:19723-19731
109. Marks Jr SC 1998 Osteoclast biology: lessons from mammalian mutations. Am J Med Genet 34:43-54
110. 3, on osteoclast-like cell formation in normal human bone marrow cultures. J Bone Miner Res 13:393-399
111. Raisz LG, Simmons HA, Sandberg AL, Canalis E 1980 Direct stimulation of bone resorption by epidermal growth factor. Endocrinology 107:270-273
112. Lorenzo JA, Quinton J, Sousa S, Raisz LG 1986 Effects of DNA and prostaglandin synthesis inhibitors on the stimulation of bone resorption by epidermal growth factor in fetal rat long-bone cultures. J Clin Invest 77:1897-1902
113. Marie PJ, Hott M, Perheentupa J 1990 Effects of epidermal growth factor on bone formation and resorption in vivo. Am J Physiol 258:E275-E281
114. Takahashi N, MacDonald BR, Hon J, Winkler ME, Derynck R, Mundy GR, Roodman GD 1986 Recombinant human transforming growth factor-α stimulates the formation of osteoclast-like cells in long-term human marrow cultures. J Clin Invest 78:894-898
115. Marks Jr SC 1995 The basic and applied biology of tooth eruption. Connect Tissue Res 32:149-157
116. Wise GE, Zhao L, Lin F 1996 Effects of epidermal growth factor (EGF) and colony-stimulating factor-1 (CSF-1) on expression of c-fos in rat mandibular molars: implications for tooth eruption. Cell Tissue Res 284:1-7
117. Normanno N, De Luca A, Aldinucci D, Maiello MR, Mancino M, D'Antonio A, De Filippi R, Pinto A 2005 Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis. Endocr Relat Cancer 12:471-482
118. Normanno N, Gullick WJ 2006 Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application? Endocr Relat Cancer 13:3-6
119. Masi L, Brandi ML 2001 Physiopathological basis of bone turnover. Q J Nucl Med 45:2-6
120. van der Zee E, Jansen I, Hoeben K, Beertsen W, Everts V 1998 EGF and IL-1 α modulate the release of collagenase, gelatinase and TIMP-1 as well as the release of calcium by rabbit calvarial bone explants. J Periodontal Res 33:65-72
121. Miettinen PJ, Chin JR, Shum L, Slavkin HC, Shuler CF, Derynck R, Werb Z 1999 Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure. Nat Genet 22:69-73
122. van der Zee E, Everts V, Hoeben K, Beertsen W 1993 Interleukin-1 α and epidermal growth factor synergistically enhance the release of collagenase by periosteal connective tissue in vitro. Matrix 13: 389-398
123. van der Zee E, Everts V, Beertsen W 1996 Cytokine-induced endogenous procollagenase stored in the extracellular matrix of soft connective tissue results in a burst of collagen breakdown following its activation. J Periodontal Res 31:483-488
124. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72
125. Baker J, Liu JP, Robertson EJ, Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82
126. Hunziker EB, Wagner J, Zapf J 1994 Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. J Clin Invest 93:1078-1086
127. Sims NA, Clement-Lacroix P, Da Ponte F, Bouali Y, Binart N, Moriggl R, Goffin V, Coschigano K, Gaillard-Kelly M, Kopchick J, Baron R, Kelly PA 2000 Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest 106:1095-1103
128. Lu valle P, Beier F 2000 Cell cycle control in growth plate chondrocytes. Front Biosci 5:493-503
129. Hock JM, Centrella M, Canalis E 1988 Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 122:254-260
130. Yakar S, Rosen CJ 2003 From mouse to man: redefining the role of insulin-like growth factor-I in the acquisition of bone mass. Exp Biol Med (Maywood) 228:245-252
131. Chernausek SD, Dickson BA, Smith EP, Hoath SB 1991 Suppression of insulin-like growth factor I during epidermal growth factor-induced growth retardation. Am J Physiol 260:E416-E421
132. Murray MA, Dickson BA, Smith EP, Hoath SB, Chernausek SD 1993 Epidermal growth factor stimulates insulin-like growth factor-binding protein-1 expression in the neonatal rat. Endocrinology 133:159-165
133. Frystyk J, Vinter-Jensen L, Skjaerbaek C, Flyvbjerg A 1996 The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats. Growth Regul 6:48-54
134. Vinter-Jensen L, Juhl CO, Frystyk J, Dajani EZ, Oksbjerg N, Flyvbjerg A 1996 The effect of epidermal growth factor on circulating levels of IGF and IGF-binding proteins in adult Goettingen minipigs. J Endocrinol 151:401-407
135. van Neck JW, Berghout EM, Vinter-Jensen L, Groffen CA, Cingel V, Dits NF, Drop SL, Flyvbjerg A 2000 The effect of epidermal growth factor and IGF-I infusion on hepatic and renal expression of the IGF-system in adult female rats. J Endocrinol 165:115-122
136. Govoni KE, Baylink DJ, Mohan S 2005 The multi-functional role of insulin-like growth factor binding proteins in bone. Pediatr Nephrol 20:261-268
137. Minuto F, Palermo C, Arvigo M, Barreca AM 2005 The IGF system and bone. J Endocrinol Invest 28:8-10
138. Kiepe D, Ciarmatori S, Haarmann A, Tonshoff B 2006 Differential expression of IGF system components in proliferating vs. differentiating growth plate chondrocytes: the functional role of IGFBP-5. Am J Physiol Endocrinol Metab 290:E363-E371
139. Kiepe D, Ciarmatori S, Hoeflich A, Wolf E, Tonshoff B 2005 Insulin-like growth factor (IGF)-I stimulates cell proliferation and induces IGF binding protein (IGFBP)-3 and IGFBP-5 gene expression in cultured growth plate chondrocytes via distinct signaling pathways. Endocrinology 146:3096-3104
140. Takaoka M, Smith CE, Mashiba MK, Okawa T, Andl CD, El-Deiry WS, Nakagawa H 2006 EGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-I. Am J Physiol Gastrointest Liver Physiol 290:G404-G416
141. O'Rear L, Longobardi L, Torello M, Law BK, Moses HL, Chiarelli F, Spagnoli A 2005 Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(β) in mesenchymal chondroprogenitor cell growth. J Mol Endocrinol 34:723-737
142. Longobardi L, O'Rear L, Aakula S, Johnstone B, Shimer K, Chytil A, Horton WA, Moses HL, Spagnoli A 2006 Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-β signaling. J Bone Miner Res 21:626-636
143. Gronthos S, Simmons PJ 1995 The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 85:929-940
144. Xian CJ, Foster BK 2006 Repair of injured articular and growth plate cartilage using mesenchymal stem cells and chondrogenic gene therapy. Curr Stem Cell Res Ther 1:213-229
145. Satomura K, Derubeis AR, Fedarko NS, Ibaraki-O'Connor K, Kuznetsov SA, Rowe DW, Young MF, Gehron Robey P 1998 Receptor tyrosine kinase expression in human bone marrow stromal cells. J Cell Physiol 177:426-438
146. Tamama K, Fan VH, Griffith LG, Blair HC, Wells A 2006 Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 24:686-695
147. Krampera M, Pasini A, Rigo A, Scupoli MT, Tecchio C, Malpeli G, Scarpa A, Dazzi F, Pizzolo G, Vinante F 2005 HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood 106:59-66
148. Mahtouk K, Hose D, Reme T, De Vos J, Jourdan M, Moreaux J, Fiol G, Raab M, Jourdan E, Grau V, Moos M, Goldschmidt H, Baudard M, Rossi JF, Cremer FW, Klein B 2005 Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells. Oncogene 24:3512-3524
149. McCarty RC, Gronthos S, Zannettino A, Foster BK, Xian CJ 2005 Development of a mesenchymal stem cell based therapy for repair of growth plate cartilage in an ovine model. Bone 36(Suppl 2):P82
150. Liu Y, Dulchavsky DS, Gao X, Kwon D, Chopp M, Dulchavsky S, Gautam SC 2006 Wound repair by bone marrow stromal cells through growth factor production. J Surg Res 136:336-341
151. Chasseing NA, Trejo YG, Bordenave RH, Bullorsky EO, Diaz NB, Rumi LS 1997 Bone marrow fibroblastic progenitors in patients with advanced breast cancer. Breast Cancer Res Treat 45:211-218
152. Hofer EL, La Russa V, Honegger AE, Bullorsky EO, Bordenave RH, Chasseing NA 2005 Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients. Stem Cells Dev 14:587-594